-
Mashup Score: 5
Soon after giving birth to her daughter, Marishia’s heart started failing. The innovative use of a drug has the potential to improve the heart function of mothers experiencing peripartum cardiomyopathy.
Source: uknow.uky.eduCategories: General Medicine News, CardiologistsTweet
-
Mashup Score: 9680
WINDER, GA—In the hours following a violent rampage in Georgia in which a lone attacker killed at least four individuals and injured nine others, citizens living in the only country where this kind of mass killing routinely occurs reportedly concluded Wednesday that there was no way to prevent the massacre from taking place. “This was […]
Source: theonion.comCategories: General Medicine News, CardiologistsTweet
-
Mashup Score: 3
UK Healthcare’s cardiovascular unit is the first in the state to study a drug helping new mothers.
Source: www.wkyt.comCategories: General Medicine News, CardiologistsTweet
-
Mashup Score: 10Kentucky: Location, transportation and limited resources - 8 month(s) ago
Kentucky is 48th in the nation when it comes to heart health and mortality. Transportation is a key driver of health disparities. There are no trains or buse…
Source: www.youtube.comCategories: General Medicine News, CardiologistsTweet
-
Mashup Score: 8Improving Cardiovascular Health in Rural United States: Role of Academic Medical Centers - 8 month(s) ago
Graphical abstract
Source: www.jacc.orgCategories: General Medicine News, CardiologistsTweet
-
Mashup Score: 1To Stent or Not to Stent in Ischemic Heart Failure: The REVIVED-BCIS2 Trial - American College of Cardiology - 1 year(s) ago
The question of revascularization in patients with heart failure (HF) and severe left ventricular (LV) systolic dysfunction is almost as old as the specialty itself. 1 The STICH (Surgical Treatment for Ischemic Heart Failure) trial did not demonstrate a survival benefit of coronary artery bypass grafting at 5 years in patients with ischemic cardiomyopathy (ICM). 2 Percutaneous coronary intervention (PCI) has not been studied in patients with severe LV dysfunction. The REVIVED-BCIS2 (Revascularization for
Source: www.acc.orgCategories: Cardiologists, Latest HeadlinesTweet
-
Mashup Score: 0Sustained Superiority of the HeartMate 3 LVAD: 5-Year Outcomes of the MOMENTUM 3 - American College of Cardiology - 1 year(s) ago
Durable left ventricular assist devices (LVADs) have demonstrated improved survival rates in patients with advanced heart failure (HF) compared with those of pharmacological therapy. 1 Sequential design improvements with each generation have led to the development of the HeartMate 3 (Abbott Laboratories, Abbott Park, Illinois) LVAD, which is a fully magnetically levitated centrifugal pump that provides frictionless, wide blood-flow passages and intrinsic pulsatility. 2 The MOMENTUM 3 (Multicenter Study
Source: www.acc.orgCategories: Cardiologists, Latest HeadlinesTweet
-
Mashup Score: 2
Bob Wilson probably had about six months to live when surgeons implanted a left ventricular assist device and arranged for a heart transplant.
Source: Norton HealthcareCategories: Cardiologists, Latest HeadlinesTweet
-
Mashup Score: 0
Bob Wilson probably had about six months to live when surgeons implanted a left ventricular assist device and arranged for a heart transplant.
Source: Norton HealthcareCategories: Cardiologists, Latest HeadlinesTweet
-
Mashup Score: 2American Heart Association Heart Walk - 2 year(s) ago
The Heart Walk is the American Heart Association’s premiere event for raising funds to save lives from USA’s #1 and #5 killers – heart disease and stroke.
Source: www2.heart.orgCategories: Cardiologists, Latest HeadlinesTweet
Does bromocriptine help in peripartum cardiomyopathy? This is the question that the REBIRTH trial is trying to answer. Happy that @UK_HealthCare is part of this study, led by Dr Dennis McNamara at @PittCardiology https://t.co/EjYpkdSCuR